If you or a loved one is suffering from advanced or end-stage heart failure (NYHA Class III or IV) and your doctor has discussed an immediate or eventual need for a heart transplant, the SynCardia temporary Total Artificial Heart (TAH) may be an option for you and your doctor to consider.
The 70cc TAH is approved as a bridge to transplant in the U.S., Europe and Canada for people who are:
If you have been told you are not eligible to receive a heart transplant because of age or certain medical conditions, the 70cc TAH is undergoing an FDA clinical trial in the U.S. as destination therapy for patients not eligible to receive a heart transplant. Learn more about the SynCardia 70cc Total Artificial Heart for Destination Therapy Study.
The 50cc TAH is approved as a bridge to transplant in Europe and Canada for people who are:
In the U.S., the 50cc TAH is undergoing an FDA clinical trial for use as a bridge to transplant in both adult and pediatric patients. Learn more about the SynCardia 50cc Total Artificial Heart as a Bridge to Transplant Study.
With more than 1,700 implants worldwide, the 70cc and 50cc TAHs have been used in patients with the following conditions that have contributed to irreversible biventricular failure:
You may also be a candidate for the SynCardia TAH if you have been:
Can the TAH be used in babies/toddlers?
Unfortunately, both the 70cc and 50cc TAHs are too large for use in babies and small children. To date, the youngest patient to receive the TAH was 9 years old.